Physician profile
Robert M Hogan
NPI 1609964055
$1,869.81
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $225 · 2021: $779 · 2022: $610.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $486.18 | 2019-2022 | |
| Pfizer INC. | $184.44 | 2019-2022 | |
| Amgen INC. | $138.52 | 2019-2022 | |
| Exeltis, USA INC. | $129.68 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $127.49 | 2021 | |
| Avion Pharmaceuticals | $71.97 | 2020-2022 | |
| Therapeuticsmd, INC. | $69.36 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $66.48 | 2021-2022 | |
| Scynexis, INC. | $59.88 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $59.45 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.04 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $47.80 | 2021-2022 | |
| Evofem Biosciences, INC. | $44.26 | 2021-2022 | |
| Hologic Sales and Service, LLC | $43.74 | 2019-2020 | |
| Biom'Up France Sas | $42.80 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $40.34 | 2022 | |
| Radius Health, INC. | $36.30 | 2019 | |
| Merck Sharp & Dohme LLC | $27.32 | 2021 | |
| Roche Diagnostics Corporation | $24.12 | 2019 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Sage Therapeutics, LLC | $16.86 | 2020 | |
| Millicent US INC | $15.31 | 2020 | |
| Agile Therapeutics, INC. | $14.97 | 2021 | |
| Vertical Pharmaceuticals, LLC | $13.74 | 2019 | |
| Coopersurgical, INC. | $13.35 | 2022 | |
| Minerva Surgical, INC | $12.41 | 2020 | |
| Collegium Pharmaceutical, INC. | $12.00 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.